Please use this identifier to cite or link to this item:
|Title:||Personalized medicine and stroke prevention: where are we?|
|Authors:||Kim, Joosup;Thrift, Amanda G;Nelson, Mark R;Bladin, Christopher F;Cadilhac, Dominique A|
|Affiliation:||Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia|
Public Health, Stroke Division, The Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia
Discipline of General Practice, School of Medicine, Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia
Eastern Health Clinical School, Monash University, Clayton, VIC, Australia
|Citation:||Vascular health and risk management 2015; 11: 601-611|
|Abstract:||There are many recommended pharmacological and non-pharmacological therapies for the prevention of stroke, and an ongoing challenge is to improve their uptake. Personalized medicine is seen as a possible solution to this challenge. Although the use of genetic information to guide health care could be considered as the apex of personalized medicine, genetics is not yet routinely used to guide prevention of stroke. Currently personalized aspects of prevention of stroke include tailoring interventions based on global risk, the utilization of individualized management plans within a model of organized care, and patient education. In this review we discuss the progress made in these aspects of prevention of stroke and present a case study to illustrate the issues faced by health care providers and patients with stroke that could be overcome with a personalized approach to the prevention of stroke.|
Research Support, Non-U.S. Gov't
personalized health care
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.